Cerevance Media Center

Current News

March 5, 2019

Industry Central Nervous System Specialist Lee Dawson, Ph.D. Joins Cerevance as VP of Neuroscience

Dawson brings 25 years of career experience spearheading drug discovery and development across companies based in the United States, Japan and the United Kingdom. Most recently, he served as Vice President of CNS drug development at Astex Pharmaceuticals, where he established and developed their global neuroscience research strategy.

READ FULL

October 9, 2018

Cerevance Appoints Ted Hibben as Chief Business Officer

A twenty-year biotechnology industry veteran, Mr. Hibben has formed over $2 billion in platform and product-based R&D collaborations. Prior to joining Cerevance, Mr. Hibben served as Chief Business Officer at Catabasis where he led partnering activities.

READ FULL

September 25, 2018

Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease

Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson’s disease.

READ FULL

February 21, 2018

Cerevance Kicks Off 2018 with Additional $10 Million of Infusions

Cerevance, a drug discovery and development company focused on brain diseases, today announced that it has received an additional equity investment as well as a non-dilutive cash payment in the first six weeks of 2018 totaling more than $10 million.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

April 2, 2024

Cerevance to Participate at the 23rd Annual Needham Virtual Health Care Conference

Date:
Monday, April 8, 2024
Time:
Check local times
Location:
Virtual
Media:
Scheduled Meetings
Read full

March 13, 2024

Cerevance Announces Presentation at Alzheimer’s Research UK Conference

Date:
Wednesday, March 20, 2024
Time:
Check local times
Location:
Liverpool, United Kingdom
Media:
Poster
Read full

February 27, 2024

Cerevance Announces Presentation at AD/PD™ 2024 International Conference

Date:
Friday, March 8, 2024
Time:
Check local times
Location:
Lisbon, Portugal
Media:
Poster
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview